Sarepta Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
SRPT on Nasdaq
Industry
Pharmaceutical Preparations
Location
215 First Street, Suite 415, Cambridge, MA

Insiders trading volume in the past year

Sarepta Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Richard Barry Director $112M May 16, 2025
Douglas S. Ingram President & CEO, Director $31.4M Nov 3, 2023
Michael Chambers Director $29.5M Mar 10, 2025
M. Kathleen Behrens Director $20.6M Mar 10, 2025
Louise Rodino-Klapac President, R&D and Tech Ops $6.64M Sep 3, 2025
Ian Michael Estepan Chief Operating Officer $6.2M Sep 3, 2025
Dallan Murray Chief Customer Officer $5.88M Mar 7, 2025
Bilal Arif Chief Tech Ops Officer $5.31M Aug 5, 2025
Ryan Brown EVP, General Counsel $2.82M Jun 21, 2024
Cristin Rothfuss EVP, General Counsel $2.81M Sep 3, 2025
Claude Nicaise Director $2.77M -$248K -8.22% Mar 12, 2025
Ryan Ho-Yan Wong Chief Financial Officer $2.73M Sep 3, 2025
Hans Wigzell Director $2.53M -$1.31M -34.2% Mar 10, 2025
William Ciambrone Evp $1.78M Mar 4, 2022
Mary Ann Gray Director $993K Mar 7, 2022
Stephen Mayo Director $902K Mar 10, 2025
Kathryn Jean Boor Director $827K -$205K -19.9% Mar 10, 2025
Deirdre P. Connelly Director $523K Mar 10, 2025

Recent Insider Transactions by Companies or Individuals for Sarepta Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.